World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Cheah E, Huang JG. Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies. World J Gastroenterol 2023; 29(10): 1539-1550 [PMID: 36970587 DOI: 10.3748/wjg.v29.i10.1539]
URL:	https://www.wjgnet.com/1007-9327/full/v29/i10/1539.htm

(154) (168) (0) (0) (0) (5408) (13)

Number	Citing Articles
1	Bernardo de Faria Moraes, Gustavo André Pedral Diniz Leite, Luisa Medeiros Visentini, Gabriel André Pedral Diniz Leite, Igor Boechat Silveira, Valbert Oliveira Costa Filho, Luis Pedro Possapp Beis, Leonardo Corrêa Süffert, Pedro Robson Costa Passos, Guilherme Grossi Lopes Cançado. Safety of advanced therapies in pregnant women with inflammatory bowel disease: a systematic review and Meta-Analysis. Journal of Crohn's and Colitis 2026; 20(3) doi: 10.1093/ecco-jcc/jjag035
2	Pooja Kushwaha, Rahila Qureshi, Nooruddin Khan, Sangita Mukhopadhyay. Revolutionizing IBD therapy: Insights into contemporary treatment strategies. International Reviews of Immunology 2026; 45(1) doi: 10.1080/08830185.2025.2563522
3	Sidsel Støy, Silvia D’Alessio, Thomas Damgaard Sandahl, Anders Dige, Anne Louise Kjølbye, Rasmus Jorgensen, Silvio Danese, Martijn van de Bunt. Lipidated IL-22 Alone or Combined with Immunomodulatory Agents Improves Disease Endpoints and Promotes Mucosal Healing in a Mouse Model of Chronic Dextran Sodium Sulfate-Induced Colitis. Digestive Diseases and Sciences 2025; 70(6) doi: 10.1007/s10620-025-09007-w
4	Xiaona Yang, Hong Guo, Min Zou. Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives. Molecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-025-00395-z
5	Taly Issa, Iyad Issa. Ethnic divergence in human leukocyte antigen-linked immunogenicity in inflammatory bowel disease. World Journal of Gastroenterology 2026; 32(25): 115526 doi: 10.3748/wjg.115526 Abstract(21) \| Core Tip(17) \| Full Article(HTML)(83) \| Full Article (PDF)-1538K(15) \| Full Article with Cover (PDF)-1901K(11) \| Full Article (XML)-175K(4) \| Audio-278K(0) \| Peer-Review Report-457K(12) \| Answering Reviewers-41K(10) \| Times Cited (0) \| Total Visits (140) \| Open
6	Hua Huang, Jiaze Ma, An Kang, Tianwei Guo, Wei Sun, Yan Xu, Lijiang Ji. Investigating the molecular mechanisms associated with ulcerative colitis through the application of single-cell combined spatial transcriptome sequencing. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1534768
7	Qing-Chun Zhao, Ying-Shi Zhang, Shuai Wang, Yu Xing, Xin-Zhu Li, Wen-Cheng Min, Kai-Si Yang, Fang-Yuan Zheng. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis. World Journal of Gastrointestinal Surgery 2024; 16(2): 571-584 doi: 10.4240/wjgs.v16.i2.571 Abstract(606) \| Core Tip(705) \| Full Article(HTML)(1863) \| Full Article (PDF)-2359K(195) \| Full Article with Cover (PDF)-2615K(155) \| Full Article (Word)-1431K(9) \| Full Article (XML)-155K(184) \| Audio-2064K(7) \| Peer-Review Report-254K(135) \| Answering Reviewers-134K(125) \| Supplementary Material-222K(120) \| Times Cited (2) \| Total Visits (3449) \| Open
8	Daniel Schweckendiek, Gerhard Rogler. Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?. Digestion 2024; 105(6) doi: 10.1159/000540421
9	Luyao Liu, Fan Zhao, Dandan Han, Xin Lü, Gang Wu, Yanglei Yi. Liquiritigenin ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function, reducing endoplasmic reticulum stress and modulating gut microbiota. Journal of Functional Foods 2024; 122 doi: 10.1016/j.jff.2024.106541
10	Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411 Abstract(733) \| Core Tip(719) \| Full Article(HTML)(2487) \| Full Article (PDF)-371K(196) \| Full Article with Cover (PDF)-1855K(229) \| Full Article (XML)-84K(122) \| Audio-1001K(13) \| Peer-Review Report-176K(129) \| Answering Reviewers-400K(261) \| Times Cited (3) \| Total Visits (3034) \| Open
11	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1 Abstract(1143) \| Core Tip(1107) \| Full Article(HTML)(4822) \| Full Article (PDF)-407K(318) \| Full Article with Cover (PDF)-1825K(410) \| Full Article (Word)-130K(54) \| Full Article (XML)-119K(204) \| Audio-14227K(36) \| Peer-Review Report-222K(212) \| Answering Reviewers-194K(168) \| Times Cited (0) \| Total Visits (5808) \| Open
12	Xiaoyu Cai, Yao Yao, Yongquan Zheng, Xuezhi Zhao. Multi-omics gut microbiome signatures for treat-to-target management in inflammatory bowel disease. Microbiological Research 2026; 309 doi: 10.1016/j.micres.2026.128511
13	Danny Con, Peter De Cruz. Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study. Intestinal Research 2024; 22(4) doi: 10.5217/ir.2023.00175

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.